Wednesday, February 10, 2010, 7:14pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Bio-Rad Laboratories, Inc. (BIO)

At 5:02AM SGT: 93.58 USD   0.00 (0.00%)  
 MORE ON BIO 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 BIO RAD LABS CL A (NYSE:BIO) Delayed quote dataEdit
Last Trade:93.58 USD
Trade Time:5:02AM SGT
Change: 0.00 (0.00%)
Prev Close:93.58
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:113.08
Day's Range:N/A - N/A
52wk Range:51.33 - 102.99
Volume:0
Avg Vol (3m):57,398.4
Market Cap:2.57B
P/E (ttm):26.23
EPS (ttm):3.57
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add BIO to Portfolio   Download Data

 HEADLINES 
•Bio-Rad Laboratories, Inc. Announces Completion of Exchange Offer
Marketwire (Fri, Feb 5)
•FUNDVIEW-Eagle Mid Cap upbeat on packaging, technology firms
at Reuters (Thu, Feb 4)
•Bio-Rad Laboratories, Inc. Announces Extension of Exchange Offer
Marketwire (Fri, Jan 29)
•Bio-Rad to Report Fourth-Quarter and Full-Year 2009 Financial Results Wednesday, February 24, 2010
Marketwire (Thu, Jan 28)
•Capital Requirements Increase In Diagnostic And Lab Equipment Sector: Northland Securities Industry Expert Picks The Stock Winners And Losers
Wall Street Transcript (Thu, Jan 28)
•Medical Equipment Manufacturers Will See Rebound In Demand As Hospitals Look For Service Differentiation To Maintain Revenues
Wall Street Transcript (Mon, Jan 25)
•Premarket roundup: Burger King, McDonald's
AP (Tue, Jan 19)
•Ahead of the Bell: Analyst downgrades Bio-Rad
AP (Tue, Jan 19)
•Bio-Rad Completes the Purchase of Certain Diagnostics Businesses of Biotest AG
Marketwire (Wed, Jan 6)
•Axis-Shield and Bio-Rad Announce Launch of New Anti-CCP Test for Bio-Rad's BioPlex 2200 System
Marketwire (Tue, Jan 5)
More Headlines for BIO...
 ANALYST 
EPS Est (next year) (Dec-09) :4.93
EPS Est (in 2 years) (Dec-10) :5.37
Avg Rec (current)*:1.7
PEG Ratio:1.69
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices